TY - JOUR
T1 - Limited Heme Oxygenase Contribution to Modulating the Severity of Salmonella enterica serovar Typhimurium Infection
AU - Sebastián, Valentina P.
AU - Moreno-Tapia, Daniela
AU - Melo-González, Felipe
AU - Hernández-Cáceres, María P.
AU - Salazar, Geraldyne A.
AU - Pardo-Roa, Catalina
AU - Farías, Mónica A.
AU - Vallejos, Omar P.
AU - Schultz, Bárbara M.
AU - Morselli, Eugenia
AU - Álvarez-Lobos, Manuel M.
AU - González, Pablo A.
AU - Kalergis, Alexis M.
AU - Bueno, Susan M.
N1 - Funding Information:
Funding: This study was supported by the following grants: Fondo Nacional de Ciencia y Tec-nología de Chile (FONDECYT numbers 1110604, 1190864, 1190830, 1170964, 1200499, 1211344 and 3210630), the Agencia Nacional de Investigación y Desarrollo (ANID)—Millennium Science Initiative Program—ICN09_016/ICN2021_045: Millennium Institute on Immunology and Immunotherapy (ICN09_016/ICN2021_045; former P09/016-F), the Regional Government of Antofagasta thtough the Innovation Fund for Competitiveness FIC-R 2017 (BIP Code: 30488811-0), and CONICYT PIA 172066. V.P.S. was supported by Vicerrectoría de Investigación doctoral grant from the Pontificia Universidad Católica de Chile. C.P.-R., M.A.F. and B.M.S. were supported by doctoral grants from the ANID Chile (3190706, 21191390, 21171014).
Funding Information:
This study was supported by the following grants: Fondo Nacional de Ciencia y Tecnología de Chile (FONDECYT numbers 1110604, 1190864, 1190830, 1170964, 1200499, 1211344 and 3210630), the Agencia Nacional de Investigación y Desarrollo (ANID)—Millennium Science Initiative Program—ICN09_016/ICN2021_045: Millennium Institute on Immunology and Immunotherapy (ICN09_016/ICN2021_045; former P09/016-F), the Regional Government of Antofagasta thtough the Innovation Fund for Competitiveness FIC-R 2017 (BIP Code: 30488811-0), and CONICYT PIA 172066. V.P.S. was supported by Vicerrectoría de Investigación doctoral grant from the Pontificia Universidad Católica de Chile. C.P.-R., M.A.F. and B.M.S. were supported by doctoral grants from the ANID Chile (3190706, 21191390, 21171014).
Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/5
Y1 - 2022/5
N2 - An important virulence trait of Salmonella enterica serovar Typhimurium (S. Typhimurium) is the ability to avoid the host immune response, generating systemic and persistent infections. Host cells play a crucial role in bacterial clearance by expressing the enzyme heme oxygenase 1 (Hmox1), which catalyzes the degradation of heme groups into Fe2+, biliverdin, and carbon monoxide (CO). The role of Hmox1 activity during S. Typhimurium infection is not clear and previous studies have shown contradictory results. We evaluated the effect of pharmacologic modulation of Hmox1 in a mouse model of acute and persistent S. Typhimurium infection by administering the Hmox1 activity inductor cobalt protoporphyrin-IX (CoPP) or inhibitor tin protoporphyrin-IX (SnPP) before infection. To evaluate the molecular mechanism involved, we measured the colocalization of S. Typhimurium and autophagosome and lysosomal markers in macrophages. Administering CoPP reduced the bacterial burden in organs of mice 5 days post-infection, while SnPP-treated mice showed bacterial loads similar to vehicle-treated mice. Furthermore, CoPP reduced bacterial loads when administered after infection in macrophages in vitro and in a persistent infection model of S. Typhimurium in vivo, while tin protoporphyrin-IX (SnPP) treatment resulted in a bacterial burden similar to vehicle-treated controls. However, we did not observe significant differences in co-localization of green fluorescent protein (GFP)-labeled S. Typhimurium with the autophagic vesicles marker microtubule-associated protein 1A/1B-light chain 3 (LC3) and the lysosomal marker lysosomal-associated membrane protein 1 (LAMP-1) in macrophages treated with CoPP. Our results suggest that CoPP can enhance antimicrobial activity in response to Salmonella infection, reducing bacterial dissemination and persistence in mice, in a CO and autophagy-independent manner.
AB - An important virulence trait of Salmonella enterica serovar Typhimurium (S. Typhimurium) is the ability to avoid the host immune response, generating systemic and persistent infections. Host cells play a crucial role in bacterial clearance by expressing the enzyme heme oxygenase 1 (Hmox1), which catalyzes the degradation of heme groups into Fe2+, biliverdin, and carbon monoxide (CO). The role of Hmox1 activity during S. Typhimurium infection is not clear and previous studies have shown contradictory results. We evaluated the effect of pharmacologic modulation of Hmox1 in a mouse model of acute and persistent S. Typhimurium infection by administering the Hmox1 activity inductor cobalt protoporphyrin-IX (CoPP) or inhibitor tin protoporphyrin-IX (SnPP) before infection. To evaluate the molecular mechanism involved, we measured the colocalization of S. Typhimurium and autophagosome and lysosomal markers in macrophages. Administering CoPP reduced the bacterial burden in organs of mice 5 days post-infection, while SnPP-treated mice showed bacterial loads similar to vehicle-treated mice. Furthermore, CoPP reduced bacterial loads when administered after infection in macrophages in vitro and in a persistent infection model of S. Typhimurium in vivo, while tin protoporphyrin-IX (SnPP) treatment resulted in a bacterial burden similar to vehicle-treated controls. However, we did not observe significant differences in co-localization of green fluorescent protein (GFP)-labeled S. Typhimurium with the autophagic vesicles marker microtubule-associated protein 1A/1B-light chain 3 (LC3) and the lysosomal marker lysosomal-associated membrane protein 1 (LAMP-1) in macrophages treated with CoPP. Our results suggest that CoPP can enhance antimicrobial activity in response to Salmonella infection, reducing bacterial dissemination and persistence in mice, in a CO and autophagy-independent manner.
KW - S. Typhimurium
KW - autolysosome
KW - autophagosome
KW - autophagy
KW - cobalt protoporphyrin-IX
KW - heme oxygenase 1
KW - tin protoporphyrin-IX
UR - http://www.scopus.com/inward/record.url?scp=85130927438&partnerID=8YFLogxK
U2 - 10.3390/antiox11061040
DO - 10.3390/antiox11061040
M3 - Article
C2 - 35739937
AN - SCOPUS:85130927438
SN - 2076-3921
VL - 11
JO - Antioxidants
JF - Antioxidants
IS - 6
M1 - 1040
ER -